3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
39
Neoplasms
37
Depression
29
Prostatic Neoplasms
23
Fatigue
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, Large B-Cell, Diffuse
13
Carcinoma, Non-Small-Cell Lung
13
Anxiety Disorders
13
Lymphoma, Mantle-Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Burkitt Lymphoma
12
Pain
11
Lymphoma, Non-Hodgkin
11
Lymphoma, B-Cell, Marginal Zone
11
Lung Neoplasms
11
Lymphoma, Large-Cell, Immunoblastic
10
Leukemia, Myeloid, Acute
10
Colorectal Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
9
Hodgkin Disease
9
Blast Crisis
9
Vomiting
8
Nausea
8
Lymphoma
8
Leukemia, Myeloid, Accelerated Phase
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Interventions
Yoga
2
Methylphenidate
2
Melatonin
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
Cognitive Behavioral Therapy
2
Behavior Therapy
2
exemestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Valeriana extract
1
Uncertainty
1
Ultraviolet Therapy
1
Triptorelin Pamoate
1
Therapeutics
1
Tamoxifen
1
Surveys and Questionnaires
1
Saline Solution
1
Psychosocial Intervention
1
Phototherapy
1
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
1
Modafinil
1
Methods
1
Methadone
1
Hypnosis
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Donepezil
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sleep Wake Disorders
×
Therapeutics
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts